

10202 5th Ave NE, Suite 200 • Seattle, WA 98125 USA
Exhibit 10.11#
SEPARATION AGREEMENT
This Separation Agreement (“Agreement”) is made as of November 15, 2025 (the “Execution Date”) between Heather Rees (“Employee”) and Atossa Therapeutics, Inc. (the “Company”). Employee and the Company will be referred to collectively as the “Parties.”
RECITALS
WHEREAS, Employee’s employment with the Company has ended effective November 15, 2025 (the “Termination Date”); and
WHEREAS, in consideration for the severance pay and other benefits set forth herein, it is the intent of Employee and the Company to resolve any and all known or unknown claims and any claims that did arise, or could have arisen, out of or in any way related to any acts, transactions or events that have occurred between the Parties to date, including Employee’s employment with and termination by the Company.
NOW, THEREFORE, in consideration of the promises and agreements contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:


10202 5th Ave NE, Suite 200 • Seattle, WA 98125 USA
tax or contribution or any penalty or interest thereon that may be incurred or demanded as a result of the receipt of the Severance Payment. Employee agrees that she has made no claims of sexual harassment or abuse and, therefore, the Parties believe that Section 162(q) of the Internal Revenue Code of 1986, as amended (the “Code”) is not applicable to this Agreement.


10202 5th Ave NE, Suite 200 • Seattle, WA 98125 USA
constitutional, contractual, statutory or other of any jurisdiction, foreign or domestic, whether known or unknown, whether in law or in equity, which Employee had or may claim to have against any of them and Employee specifically releases claims under all applicable state, federal, and local laws, including but not limited to, Title VII of the Civil Rights Act of 1964 as amended, the Fair Labor Standards Act, the Rehabilitation Act of 1973, the Family and Medical Leave Act, the Pregnancy Discrimination Act, the Employee Retirement Income Security Act, the Consolidated Omnibus Reconciliation Act of 1986, the Equal Pay Act, the Americans with Disabilities Act, the Age Discrimination in Employment Act, as well as all common law claims, whether arising in tort or contract, including tortious conduct, wrongful discharge and wrongful discharge in violation of public policy (collectively referred to as “Released Matters”).


10202 5th Ave NE, Suite 200 • Seattle, WA 98125 USA


10202 5th Ave NE, Suite 200 • Seattle, WA 98125 USA


10202 5th Ave NE, Suite 200 • Seattle, WA 98125 USA


10202 5th Ave NE, Suite 200 • Seattle, WA 98125 USA
Each counterpart signature page shall be considered to be an original, and all counterparts together shall constitute one instrument. Execution and delivery of this Agreement by sending a facsimile copy or emailing the signature page in PDF shall constitute a valid and binding execution and delivery of this Agreement by such party. Such facsimile copies or photocopies shall constitute enforceable original documents.


10202 5th Ave NE, Suite 200 • Seattle, WA 98125 USA
EMPLOYEE ACKNOWLEDGES AND UNDERSTANDS THAT THIS AGREEMENT INCLUDES A RELEASE OF ALL CLAIMS. EMPLOYEE ACKNOWLEDGES THAT THEY HAVE READ THIS AGREEMENT CAREFULLY, UNDERSTANDS ALL OF ITS TERMS AND AGREES TO THOSE TERMS KNOWINGLY, FREELY, VOLUNTARILY, AND WITHOUT DURESS. EMPLOYEE HAS BEEN ADVISED TO CONSULT WITH COUNSEL ABOUT THE TERMS AND LEGAL EFFECT OF THIS AGREEMENT.
IN WITNESS WHEREOF, the Parties have executed this instrument on the dates indicated below.
Dated: November 21, 2025 /s/ Heather Rees
Heather Rees
Atossa Therapeutics, Inc.
Dated: November 21, 2025 By: /s/ Steven Quay Steven Quay, Chief Executive Officer